Anika reports second quarter 2020 financial results

Increased total revenue 1% year-over-year to $30.7 million accelerated the commercial integration of parcus medical and arthrosurface organizations launching seven fda-cleared orthopedic and sports medicine products through q3 2020
ANIK Ratings Summary
ANIK Quant Ranking